IRIS
CIGLIANO, Antonio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.085
EU - Europa 930
AS - Asia 674
OC - Oceania 8
AF - Africa 7
Continente sconosciuto - Info sul continente non disponibili 7
SA - Sud America 7
Totale 3.718
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.067
UA - Ucraina 405
CN - Cina 351
SG - Singapore 265
DE - Germania 159
IT - Italia 150
FI - Finlandia 60
SE - Svezia 60
GB - Regno Unito 21
FR - Francia 19
CZ - Repubblica Ceca 18
CA - Canada 17
BE - Belgio 16
ID - Indonesia 16
KR - Corea 14
AU - Australia 8
BR - Brasile 7
DZ - Algeria 7
TR - Turchia 7
EU - Europa 6
NL - Olanda 6
IN - India 5
IR - Iran 4
RO - Romania 4
AT - Austria 3
AL - Albania 2
IQ - Iraq 2
JP - Giappone 2
SA - Arabia Saudita 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AZ - Azerbaigian 1
BD - Bangladesh 1
BY - Bielorussia 1
DK - Danimarca 1
HK - Hong Kong 1
IE - Irlanda 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LT - Lituania 1
LU - Lussemburgo 1
MX - Messico 1
PL - Polonia 1
RU - Federazione Russa 1
TH - Thailandia 1
Totale 3.718
Salva come PNG Salva come JPEG
Città #
Chandler 645
Jacksonville 225
Singapore 215
Princeton 184
Nanjing 102
Sassari 88
Ann Arbor 79
New York 77
Wilmington 64
Beijing 41
Dearborn 41
Nanchang 35
Boardman 33
Santa Clara 27
Mountain View 25
Ashburn 22
Shenyang 22
Woodbridge 22
Changsha 19
Brno 17
Brussels 16
Hebei 15
Andover 14
Jiaxing 14
Seoul 14
Helsinki 13
Munich 13
Norwalk 13
San Francisco 13
Toronto 13
Zhengzhou 13
Tianjin 12
Dallas 10
Houston 10
Jinan 10
Kunming 10
Ningbo 10
Fairfield 8
Falls Church 8
Guangzhou 8
Algiers 7
Hangzhou 5
Izmir 5
Melbourne 5
Cagliari 4
Milan 4
Monmouth Junction 4
Seattle 4
Augusta 3
Ficarazzi 3
Florence 3
Los Angeles 3
Rome 3
Shanghai 3
Wuxi 3
Ardabil 2
Auburn Hills 2
Beinasco 2
Cambridge 2
Como 2
Haikou 2
Hanover 2
Hefei 2
IJsselstein 2
Lanzhou 2
Messina 2
Paris 2
Riyadh 2
Romola 2
Somerville 2
St Louis 2
Taizhou 2
Vienna 2
West Jordan 2
Agropoli 1
Alghero 1
Almere Stad 1
Baghdad 1
Bangkok 1
Belo Horizonte 1
Buffalo 1
Campinas 1
Carbonia 1
Central 1
Clearwater 1
Colombo 1
Delhi 1
Dublin 1
Easton 1
Edmonton 1
Erbil 1
Espoo 1
Fazenda Rio Grande 1
Frankfurt am Main 1
Fremont 1
Fuzhou 1
Goiânia 1
Groningen 1
Heidelberg 1
Jiangmen 1
Totale 2.343
Salva come PNG Salva come JPEG
Nome #
Pathogenetic, Prognostic, and Therapeutic Role of Fatty Acid Synthase in Human Hepatocellular Carcinoma 93
Jagged 1 is a major Notch ligand along cholangiocarcinoma development in mice and humans 76
A proteomic approach to differentiate histologically classified stable and unstable plaques from human carotid arteries. IF 2009: 4.522 JCR: Q1 70
Deregulated c-Myc requires a functional HSF1 for experimental and human hepatocarcinogenesis 70
Cholesterol biosynthesis supports the growth of hepatocarcinoma lesions depleted of fatty acid synthase in mice and humans 69
4EBP1/eIF4E and p70S6K/RPS6 axes play critical and distinct roles in hepatocarcinogenesis driven by AKT and N-Ras protooncogenes 66
A functional mammalian target of rapamycin complex 1 signaling is indispensable for c-Myc-driven hepatocarcinogenesis 63
Both de novo synthetized and exogenous fatty acids support the growth of hepatocellular carcinoma cells 63
Inactivation of fatty acid synthase impairs hepatocarcinogenesis driven by AKT in mice and humans 63
MicroRNA-203 impacts on the growth, aggressiveness and prognosis of hepatocellular carcinoma by targeting MAT2A and MAT2B genes 62
Co-activation of AKT and c-Met triggers rapid hepatocellular carcinoma development via the mTORC1/FASN pathway in mice 60
The mTORC2-Akt1 Cascade Is Crucial for c-Myc to Promote Hepatocarcinogenesis in Mice and Humans 60
Activation of β-Catenin and Yap1 in Human Hepatoblastoma and Induction of Hepatocarcinogenesis in Mice. 60
Loss of Fbxw7 synergizes with activated AKT signaling to promote c-Myc dependent cholangiocarcinogenesis 59
Evaluation of plasma glycosaminoglycans levels and structure in patients undergoing carotid endarterectomy 59
Oncogene dependent requirement of fatty acid synthase in hepatocellular carcinoma 56
Differential distribution of structural components and hydration in aortic and pulmonary heart valve conduits: Impact of detergent-based cell removal. IF 2010: 4.824 JCR: Q1 56
Combined CDK4/6 and pan-mTOR inhibition is synergistic against intrahepatic cholangiocarcinoma 55
Association between human plasma chondroitin sulphate isomers and carotid atherosclerotic plaque 54
Evaluation of human serum albumin sulfhydryl groups oxidation in plasma and atherosclerotic plaque extracts 54
Inactivation of Spry2 accelerates AKT-driven hepatocarcinogenesis via activation of MAPK and PKM2 pathways. 52
Molecular and metabolic changes in human liver clear cell foci resemble the alterations occurring in rat hepatocarcinogenesis. 51
Cabozantinib-based combination therapy for the treatment of hepatocellular carcinoma 50
Apolipoprotein Profiles in Atherosclerotic Disease 49
Evaluation of human serum albumin sulfhydryl groups oxidation in plasma and atherosclerotic plaque extracts 49
Apolipoprotein Profiles in Atherosclerotic Disease 49
Apolipoprotein profiles in atherosclerotic disease 48
The Epidermal Growth Factor Receptor (EGFR) Inhibitor Gefitinib Reduces but Does Not Prevent Tumorigenesis in Chemical and Hormonal Induced Hepatocarcinogenesis Rat Models 48
Functional crosstalk between AKT/mTOR and Ras/MAPK pathways in hepatocarcinogenesis: implications for the treatment of human liver cancer. 48
Co-activation of PIK3CA and Yap promotes development of hepatocellular and cholangiocellular tumors in mouse and human liver 47
Structural analisys of plasma glycosaminoglycans in patients with atheromatous lesions 47
SKP2 cooperates with N-Ras or AKT to induce liver tumor development in mice 47
SNAI1 promotes the cholangiocellular phenotype, but not epithelial-mesenchymal transition, in a murine hepatocellular carcinoma model 46
Pan-mTOR inhibitor MLN0128 is effective against intrahepatic cholangiocarcinoma in mice 46
Differential requirement for de novo lipogenesis in cholangiocarcinoma and hepatocellular carcinoma of mice and humans 46
Ultrasensitive Capillary Zone Electrophoresis (CZE) for glycosaminoglycan analisys in normal human plasma 45
Loss of pten synergizes with c-met to promote hepatocellular carcinoma development via mTORC2 pathway 44
Modification of the base excision repair enzyme MBD4 by the small ubiquitin-like molecule SUMO1 44
Evaluation of plasma glycosaminoglycans levels and structure in patients undergoingcarotid endarterectomy 43
Apolipoprotein profiles in atherosclerotic disease 43
TEA Domain Transcription Factor 4 Is the Major Mediator of Yes-Associated Protein Oncogenic Activity in Mouse and Human Hepatoblastoma 43
Crenigacestat, a selective NOTCH1 inhibitor, reduces intrahepatic cholangiocarcinoma progression by blocking VEGFA/DLL4/MMP13 axis 43
PI3K/AKT/mTOR pathway plays a major pathogenetic role in glycogen accumulation and tumor development in renal distal tubules of rats and men. 43
Human serum albumin sulfhydryl groups oxidation in plasma and atherosclerotic plaque extracts 43
Inhibition of HSF1 suppresses the growth of hepatocarcinoma cell lines in vitro and AKT-driven hepatocarcinogenesis in mice 42
Oncogene-dependent addiction to carbohydrate-responsive element binding protein in hepatocellular carcinoma 41
Inhibition of MELK Protooncogene as an Innovative Treatment for Intrahepatic Cholangiocarcinoma 41
Efficacy of MEK inhibition in a K-Ras-driven cholangiocarcinoma preclinical model 41
Proteomic study of differential protein expression in stable and unstable human atherosclerotic plaque 40
Glycosaminoglycan content and distribution in human normal and varicose veins 40
PI3K/AKT/mTOR-dependent stabilization of oncogenic far-upstream element binding proteins in hepatocellular carcinoma cells 40
New Capillary Zone Electrophoresis (CZE) method for glycosaminoglycan analysis 40
Human serum albumin Cys34 oxidative modifications after infiltration in the carotid atherosclerotic plaque 39
Pivotal role of fatty acid synthase in c-myc driven hepatocarcinogenesis 37
Hippo Cascade Controls Lineage Commitment of Liver Tumors in Mice and Humans 37
Role of the Notch signaling in cholangiocarcinoma 36
GLYCOSAMINOGLYCAN DIVERSITY IN MARINE SPONGE EXTRACELLULAR MATRIX 35
Glycosaminoglycans and fabry’s disease 35
Fine structure of glycosaminoglycans from fresh and decellularized porcine cardiac valves and pericardium 35
Plasma levels of C-reactive protein, leptin and glycosaminoglycans during spontaneous menstrual cycle: differences between ovulatory and anovulatory cycles 34
Transcriptomic and Proteomic Analysis of Clear Cell Foci (CCF) in the Human Non-Cirrhotic Liver Identifies Several Differentially Expressed Genes and Proteins with Functions in Cancer Cell Biology and Glycogen Metabolism 34
The Hippo Effector Transcriptional Coactivator with PDZ-Binding Motif Cooperates with Oncogenic β-Catenin to Induce Hepatoblastoma Development in Mice and Humans 34
Aortic and pulmonary bioprosthetic heart valves: an insight on glycosaminoglycan distribution and fine structure in decellularized porcine scaffolds for tissue engineering purposes 33
Evaluation of human serum albumin sulfhydryl groups oxidation in plasma and atherosclerotic plaque extracts 33
Structural analysis of glycosaminoglycans from fresh and decellularized porcine aortic and pulmonary valves 32
Proteomic study of differential protein expression in stable and unstable human atherosclerotic plaque 32
Structural analysis of glycosaminoglycans from fresh and decellularized porcine aortic and pulmonary valves 32
Structural analysis of plasma glycosaminoglycans in patients undergoing carotid endarterectomy 30
Erratum: Frizzled-10 extracellular vesicles plasma concentration is associated with tumoral progression in patients with colorectal and gastric cancer (Journal of Oncology (2019) 2019 (2715968) DOI: 10.1155/2019/2715968) 30
Structural analysis of glycosaminoglycans from fresh porcine aortic valves 29
Distinct and Overlapping Roles of Hippo Effectors YAP and TAZ During Human and Mouse Hepatocarcinogenesis. 29
Nuclear localization dictates hepatocarcinogenesis suppression by glycine N-methyltransferase 29
Structural analysis of glycosaminoglycans from fresh and decellularized porcine aortic and pulmonary valves 29
Oncogenic potential of N-terminal deletion and S45Y mutant β-catenin in promoting hepatocellular carcinoma development in mice 25
The Hippo pathway effector TAZ induces intrahepatic cholangiocarcinoma in mice and is ubiquitously activated in the human disease 24
Functional role of SGK3 in PI3K/Pten driven liver tumor development 24
Tankyrase inhibitors suppress hepatocellular carcinoma cell growth via modulating the Hippo cascade 24
Focal adhesion kinase activation limits efficacy of Dasatinib in c-Myc driven hepatocellular carcinoma 24
MEK inhibition suppresses K-Ras wild-type cholangiocarcinoma in vitro and in vivo via inhibiting cell proliferation and modulating tumor microenvironment 23
CD90 is regulated by notch1 and hallmarks a more aggressive intrahepatic cholangiocarcinoma phenotype 23
Central role of mTORC1 downstream of YAP/TAZ in hepatoblastoma development 23
Glycosaminoglycan diversity in marine sponge extracellular matrix 22
Overexpression of SMAD7 activates the YAP/NOTCH cascade and promotes liver carcinogenesis in mice and humans 21
Corrigendum to ‘TAZ is indispensable for c-MYC-induced hepatocarcinogenesis’ [J Hepatol (2022) 123–134] (Journal of Hepatology (2022) 76(1) (123–134), (S016882782102016X), (10.1016/j.jhep.2021.08.021)) 21
Current challenges to underpinning the genetic basis for cholangiocarcinoma 20
Thymine DNA glycosylase is essential for active DNA demethylation by linked deamination-base excision repair 20
Preclinical Models of Hepatocellular Carcinoma: Current Utility, Limitations, and Challenges 18
Frizzled-10 Extracellular Vesicles Plasma Concentration Is Associated with Tumoral Progression in Patients with Colorectal and Gastric Cancer 14
HSF1 is a prognostic determinant and therapeutic target in intrahepatic cholangiocarcinoma 12
eIF4A1 Is a Prognostic Marker and Actionable Target in Human Hepatocellular Carcinoma 12
Signaling and molecular networks related to development and inflammation involved in CCA initiation and progression 12
Molecular and metabolic changes in human clear cell liver foci 9
RASSF1A independence and early galectin-1 upregulation in PIK3CA-induced hepatocarcinogenesis: new therapeutic venues 8
Quantification of liver proton-density fat fraction in 7.1T preclinical MR systems: Impact of the fitting technique 8
TAZ is indispensable for c-MYC-induced hepatocarcinogenesis 7
Hepatocellular glycogenotic foci after combined intraportal pancreatic islet transplantation and knockout of the carbohydrate responsive element binding protein in diabetic mice 7
TGF-β as Multifaceted Orchestrator in HCC Progression: Signaling, EMT, Immune Microenvironment, and Novel Therapeutic Perspectives 6
Fatty Acid Synthase Promotes Hepatocellular Carcinoma Growth via S-Phase Kinase-Associated Protein 2/p27KIP1 Regulation 4
Totale 3.812
Salva come PNG Salva come JPEG
Categoria #
all - tutte 23.617
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.617
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020370 0 0 0 0 60 39 88 9 74 18 82 0
2020/2021586 61 4 118 5 67 29 84 4 91 83 33 7
2021/2022479 37 3 2 4 13 10 21 28 45 24 81 211
2022/20231.114 116 115 48 178 106 167 0 113 189 7 40 35
2023/2024299 52 18 5 13 83 37 2 14 0 5 29 41
2024/2025403 26 28 175 73 101 0 0 0 0 0 0 0
Totale 3.812